📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. (2024)

First Author: Balikçi E

Attributed to: ADP-ribosylation of DNA in Mycobacterium tuberculosis funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.4c00072

PubMed Identifier: 38635563

Publication URI: http://europepmc.org/abstract/MED/38635563

Type: Journal Article/Review

Volume: 67

Parent Publication: Journal of medicinal chemistry

Issue: 9

ISSN: 0022-2623